questionText: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 26 October 2023 to Question 203897 on Attention Deficit Hyperactivity Disorder: Drugs, what recent steps his Department has taken to help ensure an adequate supply of (a) methylphenidate, (b) lisdexamfetamine and (c) guanfacine.
answerText: The Department has been working with manufacturers of medicines used for the management of attention deficit hyperactivity disorder to ensure that action is taken to address the supply issues as quickly as possible. As a result of our continued work with ...
heading: Attention Deficit Hyperactivity Disorder: Drugs